VictoryShares Pioneer Asset-Based Inc ETF ABI
24.44 USD -0.05 (-0.22%)
Nov 12, 2026, 9:34 AM EST
24.44 Day range 24.44
24.36 52-week range 25.10
- YTD
- -1.49%
- 1 year
- -1.85%
News
benzinga.com Bloomberg: Will Anheuser-Busch Explore M&A Opportunity Outside Of Alcohol? 
benzinga.com Anheuser-Busch InBev, Constellation Brands Announce Revised Agreement for Divestiture of Grupo Modelo's US Business 
benzinga.com Architecture Indexes and Homebuilder ETF: Has A Turning Point in Construction Arrived? 
benzinga.com UPDATE: KeyBanc Upgrades Shares of Terex to Buy from Hold; Reiterates Buy for Oshkosh - benzinga.com Architecture Indexes Support the Position That the Turning Point in Construction May Have Arrived
- benzinga.com Vermillion Announces Positive Top-Line Data from Intended Use Study for Peripheral Artery Disease (PAD)
benzinga.com Gain in Architecture Billings Index Highest in 4 Yrs. - benzinga.com March Architecture Index Holds Steady
- benzinga.com Architecture Billings Index Continues Positive Momentum, Reaches Pre-Recession Level in Dec.
- benzinga.com Architecture Billings Index Hits Pre-Recession Level
- benzinga.com AIA's Architecture Billings Index (ABI) Declined 1.7 Points To 48.7, Oppenheimer Reports
- benzinga.com Architecture Indexes Back to Pre-Recession Levels
benzinga.com The Architecture Billing Index (A Leading Indicator) Improves in Aug. and In 6 Out of the Last 7 Months 
benzinga.com The Architecture Billing Index (Leading Indicator) Improves in July and In 5 Out of the Last 6 Months - benzinga.com Oppenheimer’s Architecture Billing index Update (ESSX, MGRC, RBA)
- benzinga.com Market Roundup (GOOG, CMCSA, GE)
- benzinga.com Dr. Manfred Beilharz, Co-Investigator in Australian Influenza Phase 2 Clinical Trial, Interviewed on 6PR Nightline Program Regarding Interferon and Influenza AMARILLO, TX--(Marketwire - August 17, 2009) - Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced that Dr. Manfred Beilharz, Chairman of the Department of Microbiology and Immunology,…